FRANK E THOMAS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANK E THOMAS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANK E THOMAS. FRANK E THOMAS is EVP, Chief Operating Officer in AMAG PHARMACEUTICALS INC. ($AVM) and President & COO in AMAG PHARMACEUTICALS INC. ($AVM) and VP, Finance & CFO in ESPERION THERAPEUTICS INC/MI ($ESPR) and Director in ZAFGEN, INC. ($ZFGN) and Director in Spero Therapeutics, Inc. ($SPRO) and See Remarks in Orchard Therapeutics plc ($ORTX).
Latest Insider Trading Transactions of FRANK E THOMAS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, ESPR, LRMR, ORTX, SPRO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 01 2021 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Option Exercise | M | 2.44 | 10,000 | 24,400 | 426,185 | |
Feb 01 2021 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Buy | M | 2.44 | 10,000 | 24,400 | 42,081 | 32.1 K to 42.1 K (+31.17 %) |
Jan 12 2021 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Payment of Exercise | F | 6.72 | 3,706 | 24,904 | 32,081 | 35.8 K to 32.1 K (-10.36 %) |
Jan 12 2021 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Grant | A | 0.00 | 10,667 | 0 | 35,787 | 25.1 K to 35.8 K (+42.46 %) |
Jan 12 2021 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Payment of Exercise | F | 6.72 | 3,706 | 24,904 | 32,081 | 35.8 K to 32.1 K (-10.36 %) |
Jan 12 2021 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Grant | A | 0.00 | 10,667 | 0 | 35,787 | 25.1 K to 35.8 K (+42.46 %) |
Jan 06 2021 | SPRO | Spero Therapeutics ... | THOMAS FRANK E | Director | Option Exercise | A | 17.93 | 1,314 | 23,560 | 1,314 | |
Oct 27 2020 | SPRO | Spero Therapeutics ... | THOMAS FRANK E | Director | Option Exercise | A | 13.52 | 7,500 | 101,400 | 7,500 | |
Sep 30 2020 | ZFGN | Larimar Therapeuti ... | THOMAS FRANK E | Director | Option Exercise | A | 11.90 | 16,600 | 197,540 | 16,600 | |
Jun 15 2020 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Option Exercise | M | 2.44 | 10,000 | 24,400 | 436,185 | |
Jun 15 2020 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Buy | M | 2.44 | 10,000 | 24,400 | 25,120 | 15.1 K to 25.1 K (+66.14 %) |
Apr 03 2020 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Option Exercise | A | 7.05 | 150,000 | 1,057,500 | 150,000 | |
Jan 06 2020 | SPRO | Spero Therapeutics ... | THOMAS FRANK E | Director | Option Exercise | A | 9.87 | 2,704 | 26,688 | 2,704 | |
Jan 06 2020 | ORTX | Orchard Therapeuti ... | THOMAS FRANK E | See Remarks | Option Exercise | A | 13.58 | 200,000 | 2,716,000 | 200,000 | |
Jun 27 2019 | ZFGN | ZAFGEN, INC. | THOMAS FRANK E | Director | Option Exercise | A | 1.25 | 27,000 | 33,750 | 27,000 | |
Jun 05 2019 | SPRO | Spero Therapeutics ... | THOMAS FRANK E | Director | Option Exercise | A | 10.67 | 6,073 | 64,799 | 6,073 | |
Jun 07 2018 | ZFGN | ZAFGEN, INC. | THOMAS FRANK E | Director | Option Exercise | A | 6.79 | 20,000 | 135,800 | 20,000 | |
Jun 06 2018 | SPRO | Spero Therapeutics ... | THOMAS FRANK E | Director | Option Exercise | A | 11.54 | 6,073 | 70,082 | 6,073 | |
Jun 23 2017 | ZFGN | ZAFGEN, INC. | THOMAS FRANK E | Director | Option Exercise | A | 3.95 | 14,500 | 57,275 | 14,500 | |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Option Exercise | A | 23.75 | 30,000 | 712,500 | 30,000 | |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Grant | A | 0.00 | 12,000 | 0 | 138,195 | 126.2 K to 138.2 K (+9.51 %) |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Grant | A | 0.00 | 12,000 | 0 | 126,195 | 114.2 K to 126.2 K (+10.51 %) |
Jul 01 2016 | ZFGN | ZAFGEN, INC. | THOMAS FRANK E | Director | Option Exercise | A | 5.99 | 12,000 | 71,880 | 12,000 | |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Option Exercise | A | 25.18 | 40,000 | 1,007,200 | 40,000 | |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Grant | A | 0.00 | 17,000 | 0 | 114,195 | 97.2 K to 114.2 K (+17.49 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 26.28 | 515 | 13,534 | 97,195 | 97.7 K to 97.2 K (-0.53 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 458 | 12,371 | 97,710 | 98.2 K to 97.7 K (-0.47 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 1,361 | 36,761 | 98,168 | 99.5 K to 98.2 K (-1.37 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 7,417 | 200,333 | 99,529 | 106.9 K to 99.5 K (-6.94 %) |
Aug 21 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 61.71 | 2,363 | 145,821 | 106,946 | 109.3 K to 106.9 K (-2.16 %) |
Aug 07 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Option Exercise | M | 14.91 | 15,000 | 223,650 | 45,000 | |
Aug 07 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Sell | S | 66.85 | 15,000 | 1,002,750 | 109,309 | 124.3 K to 109.3 K (-12.07 %) |
Aug 07 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Buy | M | 14.91 | 15,000 | 223,650 | 124,309 | 109.3 K to 124.3 K (+13.72 %) |
Jul 15 2015 | ZFGN | ZAFGEN, INC. | THOMAS FRANK E | Director | Option Exercise | A | 37.15 | 12,000 | 445,800 | 12,000 | |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Sell | S | 69.76 | 7,996 | 557,801 | 109,309 | 117.3 K to 109.3 K (-6.82 %) |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Sell | S | 69.27 | 12,004 | 831,517 | 117,305 | 129.3 K to 117.3 K (-9.28 %) |
Mar 05 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Payment of Exercise | F | 49.70 | 4,279 | 212,666 | 129,309 | 133.6 K to 129.3 K (-3.20 %) |
Feb 27 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Option Exercise | A | 49.46 | 25,000 | 1,236,500 | 25,000 | |
Feb 27 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Grant | A | 0.00 | 12,500 | 0 | 133,588 | 121.1 K to 133.6 K (+10.32 %) |
Feb 12 2004 | ESPR | ESPERION THERAPEUT ... | THOMAS FRANK E | VP, Finance & CFO | Option Exercise | D | 0.00 | 102,201 | 0 | 0 | |
Feb 09 2004 | ESPR | ESPERION THERAPEUT ... | THOMAS FRANK E | VP, Finance & CFO | Option Exercise | M | 0.00 | 46,799 | 0 | 102,201 | |
Feb 09 2004 | ESPR | ESPERION THERAPEUT ... | THOMAS FRANK E | VP, Finance & CFO | Sell | U | 35.00 | 48,778 | 1,707,230 | 0 | 48.8 K to 0 (-100.00 %) |
Feb 09 2004 | ESPR | ESPERION THERAPEUT ... | THOMAS FRANK E | VP, Finance & CFO | Buy | M | 0.00 | 46,799 | 0 | 48,778 | 2 K to 48.8 K (+2,364.78 %) |
Page: 1